Opus Genetics (IRD) Asset Utilization Ratio (2020 - 2026)

Opus Genetics (IRD) has 7 years of Asset Utilization Ratio data on file, last reported at 0.2 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 36.22% year-over-year to 0.2 in Q1 2026; TTM through Mar 2026 was 0.2, a 36.22% decrease from a year earlier, with the FY2025 full-year figure at 0.33, up 34.64% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.2, down from 0.33 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for IRD reached as high as 1.25 in Q4 2022 and fell as low as 0.03 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.47 across 5 years, with a median of 0.35 in 2023.
• Across the five-year window, Asset Utilization Ratio jumped 5145.76% in 2022 and slumped 83.21% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 1.25 in 2022, then tumbled by 71.9% to 0.35 in 2023, then retreated by 19.22% to 0.28 in 2024, then rose by 15.52% to 0.33 in 2025, then tumbled by 37.71% to 0.2 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.2 in Q1 2026, 0.33 in Q4 2025, and 0.39 in Q3 2025.